Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Association Between the NFKB1-94ins/del ATTG Polymorphism (rs28362491) and Coronary Artery Disease: A Systematic Review and Meta-Analysis.

Chen QJ, Lai HM, Zhao L, Ma YT, Li XM, Zhai H, Zhou Y, He CH, Chen BD, Liu F, Yang YN.

Genet Test Mol Biomarkers. 2016 Mar;20(3):105-11. doi: 10.1089/gtmb.2015.0242. Epub 2016 Jan 22. Review.

PMID:
26799199
2.

Genetic Variation in NFKB1 and NFKBIA and Susceptibility to Coronary Artery Disease in a Chinese Uygur Population.

Lai HM, Li XM, Yang YN, Ma YT, Xu R, Pan S, Zhai H, Liu F, Chen BD, Zhao Q.

PLoS One. 2015 Jun 15;10(6):e0129144. doi: 10.1371/journal.pone.0129144. eCollection 2015.

3.

-94 ATTG insertion/deletion polymorphism of the NFKB1 gene is associated with coronary artery disease in Han and Uygur women in China.

Yang YN, Zhang JY, Ma YT, Xie X, Li XM, Liu F, Chen BD, Dong XH, Zheng YY, Pan S, Zhai H, Li DZ, Chen QJ.

Genet Test Mol Biomarkers. 2014 Jun;18(6):430-8. doi: 10.1089/gtmb.2013.0431. Epub 2014 May 12.

4.

An updated meta-analysis of 37 case-control studies on the association between NFKB1 -94ins/del ATTG promoter polymorphism and cancer susceptibility.

Luo YQ, Wang D, Gong T, Zhu J.

Oncotarget. 2016 Sep 6;7(36):58659-58670. doi: 10.18632/oncotarget.10808. Review.

5.

NFKB1 -94insertion/deletion ATTG polymorphism and cancer risk: Evidence from 50 case-control studies.

Fu W, Zhuo ZJ, Chen YC, Zhu J, Zhao Z, Jia W, Hu JH, Fu K, Zhu SB, He J, Liu GC.

Oncotarget. 2017 Feb 7;8(6):9806-9822. doi: 10.18632/oncotarget.14190. Review.

6.

The functional 4-bp insertion/deletion ATTG polymorphism in the promoter region of NF-KB1 reduces the risk of BC.

Eskandari-Nasab E, Hashemi M, Ebrahimi M, Amininia S.

Cancer Biomark. 2016;16(1):109-15. doi: 10.3233/CBM-150546.

PMID:
26835711
7.

Meta-analysis of studies on the association between the NF-κB1-94ins/del ATTG promoter polymorphism and cancer.

Nian X, Zhang W, Li L, Sun Y, Sun E, Han R.

Tumour Biol. 2014 Dec;35(12):11921-31. doi: 10.1007/s13277-014-2470-3. Epub 2014 Sep 5.

PMID:
25190017
8.

Role of inflammatory gene polymorphisms in left ventricular dysfunction (LVD) susceptibility in coronary artery disease (CAD) patients.

Mishra A, Srivastava A, Mittal T, Garg N, Mittal B.

Cytokine. 2013 Mar;61(3):856-61. doi: 10.1016/j.cyto.2012.12.020. Epub 2013 Jan 26.

PMID:
23357300
9.

Association of NFKB1 -94ins/delATTG promoter polymorphism with susceptibility to autoimmune and inflammatory diseases: a meta-analysis.

Zou YF, Wang F, Feng XL, Tao JH, Zhu JM, Pan FM, Su H.

Tissue Antigens. 2011 Jan;77(1):9-17. doi: 10.1111/j.1399-0039.2010.01559.x. Epub 2010 Sep 6.

PMID:
21155719
10.

Association between the NFKB1-94ins/del ATTG polymorphism and cancer risk: an updated meta-analysis.

Duan W, Wang E, Zhang F, Wang T, You X, Qiao B.

Cancer Invest. 2014 Aug;32(7):311-20. doi: 10.3109/07357907.2014.911881. Epub 2014 May 14.

PMID:
24827594
11.

Mutant DD genotype of NFKB1 gene is associated with the susceptibility and severity of coronary artery disease.

Luo JY, Li XM, Zhou Y, Zhao Q, Chen BD, Liu F, Chen XC, Zheng H, Ma YT, Gao XM, Yang YN.

J Mol Cell Cardiol. 2017 Feb;103:56-64. doi: 10.1016/j.yjmcc.2017.01.005. Epub 2017 Jan 12.

PMID:
28088561
12.

Functional promoter -94 ins/del ATTG polymorphism in NFKB1 gene is associated with bladder cancer risk in a Chinese population.

Li P, Gu J, Yang X, Cai H, Tao J, Yang X, Lu Q, Wang Z, Yin C, Gu M.

PLoS One. 2013 Aug 20;8(8):e71604. doi: 10.1371/journal.pone.0071604. eCollection 2013.

13.

The functional -94 insertion/deletion ATTG polymorphism in the promoter region of NFKB1 gene increases the risk of sporadic colorectal cancer.

Mohd Suzairi MS, Tan SC, Ahmad Aizat AA, Mohd Aminudin M, Siti Nurfatimah MS, Andee ZD, Ankathil R.

Cancer Epidemiol. 2013 Oct;37(5):634-8. doi: 10.1016/j.canep.2013.05.007. Epub 2013 Jun 24.

PMID:
23806437
14.

Association and interaction of NFKB1 rs28362491 insertion/deletion ATTG polymorphism and PPP1R13L and CD3EAP related to lung cancer risk in a Chinese population.

Yin J, Wang H, Vogel U, Wang C, Hou W, Ma Y.

Tumour Biol. 2016 Apr;37(4):5467-73. doi: 10.1007/s13277-015-4373-3. Epub 2015 Nov 13.

PMID:
26563375
15.

Association of NFKB1 -94ins/del ATTG promoter polymorphism with susceptibility to and phenotype of Graves' disease.

Kurylowicz A, Hiromatsu Y, Jurecka-Lubieniecka B, Kula D, Kowalska M, Ichimura M, Koga H, Kaku H, Bar-Andziak E, Nauman J, Jarzab B, Ploski R, Bednarczuk T.

Genes Immun. 2007 Oct;8(7):532-8. Epub 2007 Aug 9.

PMID:
17690684
16.

Association between NFKB1 -94ins/delATTG promoter polymorphism and cancer risk: a meta-analysis.

Zou YF, Yuan FL, Feng XL, Tao JH, Ding N, Pan FM, Wang F.

Cancer Invest. 2011 Jan;29(1):78-85. doi: 10.3109/07357907.2010.535054.

PMID:
21166501
17.

Association between NFKB1 -94ins/del ATTG Promoter Polymorphism and Cancer Susceptibility: An Updated Meta-Analysis.

Yang X, Li P, Tao J, Qin C, Cao Q, Gu J, Deng X, Wang J, Liu X, Wang Z, Wu B, Gu M, Lu Q, Yin C.

Int J Genomics. 2014;2014:612972. doi: 10.1155/2014/612972. Epub 2014 May 7. Review.

18.

A functional insertion/deletion polymorphism (-94 ins/del ATTG) in the promoter region of the NFKB1 gene is related to the risk of renal cell carcinoma.

Cai H, Sun L, Cui L, Cao Q, Qin C, Zhang G, Mao X, Wang M, Zhang Z, Shao P, Yin C.

Urol Int. 2013;91(2):206-12. doi: 10.1159/000345630. Epub 2012 Dec 29.

PMID:
23295440
19.

Genetic association between NFKB1 -94 ins/del ATTG Promoter Polymorphism and cancer risk: a meta-analysis of 42 case-control studies.

Wang D, Xie T, Xu J, Wang H, Zeng W, Rao S, Zhou K, Pei F, Zhou Z.

Sci Rep. 2016 Jul 22;6:30220. doi: 10.1038/srep30220.

20.

A functional promoter polymorphism in NFKB1 increases susceptibility to endometriosis.

Zhou B, Rao L, Peng Y, Wang Y, Qie M, Zhang Z, Song Y, Zhang L.

DNA Cell Biol. 2010 May;29(5):235-9. doi: 10.1089/dna.2009.0992.

PMID:
20218898

Supplemental Content

Support Center